SG Americas Securities’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$695K Buy
+50,000
New +$18.5M ﹤0.01% 2127
2025
Q2
Sell
-22,800
Closed -$774K 3126
2025
Q1
$774K Hold
22,800
﹤0.01% 1402
2024
Q4
$1.84M Hold
22,800
0.01% 622
2024
Q3
$324K Hold
22,800
﹤0.01% 2077
2024
Q2
$253K Buy
+22,800
New +$12.1M ﹤0.01% 2051
2021
Q1
Sell
-33,800
Closed -$17K 3352
2020
Q4
$17K Hold
33,800
﹤0.01% 3213
2020
Q3
$442K Hold
33,800
﹤0.01% 1709
2020
Q2
$829K Sell
33,800
-50,000
-60% -$13.3M 0.01% 1597
2020
Q1
$3.98M Buy
83,800
+14,500
+21% +$3.95M 0.04% 464
2019
Q4
$492K Buy
69,300
+16,100
+30% +$4.43M ﹤0.01% 1798
2019
Q3
$2.08M Hold
53,200
0.02% 936
2019
Q2
$930K Hold
53,200
0.01% 1481
2019
Q1
$1.07M Buy
+53,200
New +$15.4M 0.01% 1240
2017
Q2
Sell
-150,000
Closed -$758K 3259
2017
Q1
$758K Buy
150,000
+99,800
+199% +$15.9M 0.01% 1561
2016
Q4
$19K Hold
50,200
﹤0.01% 2993
2016
Q3
$349K Hold
50,200
﹤0.01% 2030
2016
Q2
$404K Hold
50,200
﹤0.01% 1825
2016
Q1
$466K Hold
50,200
﹤0.01% 1782
2015
Q4
$512K Buy
+50,200
New +$6.92M ﹤0.01% 1581
2014
Q1
Sell
-133,200
Closed -$16K 2497
2013
Q4
$16K Sell
133,200
-215,900
-62% -$19.2M ﹤0.01% 2526
2013
Q3
$640K Buy
349,100
+90,100
+35% +$7.72M ﹤0.01% 1492
2013
Q2
$754K Buy
+259,000
New +$19.4M ﹤0.01% 1083

Other funds holding ELV

SG Americas Securities's ELV Position: Q2 2026 in Review

SG Americas Securities increased its Elevance Health (ELV) stake by 72% in Q2 2026, buying an estimated $213M and bringing the position to 1,372,089 shares worth $531M. The position accounts for 0.3% of the portfolio, ranked #52.

SG Americas Securities first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • SG Americas Securities held 1,372,089 shares of Elevance Health worth $531M as of Q2 2026.
  • SG Americas Securities bought 575,536 Elevance Health shares in Q2 2026, an estimated $213M.
  • Elevance Health made up 0.3% of SG Americas Securities's portfolio in Q2 2026, its #52 holding.
  • SG Americas Securities first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.